Rev1 Ventures September Founder’s Story | Mike Triplett, Co-Founder and CEO of Myonexus Therapeutics
September 18 @ 11:30 am - 1:00 pm
Join us on 9/18 to the success story of how Columbus-based Myonexus Therapeutics was acquired for $165MM earlier this year.
About this Event
Join Rev1 Ventures for the September Founder’s Story as Mike Triplett, Co-Founder and CEO of BioOhio member Myonexus Therapeutics discusses the journey of Myonexus Therapeutics. From spinning out technology from the Research Institute at Nationwide Children’s Hospital, through the commercialization process, all the way to acquisition of Myonexus Therapeutics by fellow BioOhio member Sarepta Therapeutics.
About the Speaker: Michael Triplett
Dr. Michael Triplett is Co-founder and Partner at 1787 Bio, LLC, a diversified gene and cell therapy company headquartered in Columbus, Ohio, and President of Carmen Partners LLC, a life science ventures, commercialization, and innovation consultancy.
Dr. Triplett co-founded and served as President and CEO of Myonexus Therapeutics. Prior to co-founding Myonexus Therapeutics, Dr. Triplett served as Chief Executive Officer of N8 Medical, a clinical stage combination device company with Breakthrough designation for its lead antimicrobial endotracheal tube product.
Dr. Triplett is currently leading the InnovateOhio Life Sciences Working Group for Ohio Lieutenant Governor Jon Husted with the mission to propose a life sciences economic development strategy for the State of Ohio.
The Rev1 Founder’s Story series features first-hand insights into the triumphs, trials, and tribulations of companies working within the tech industry. Each luncheon features a founding story and tips on a topic, plus delicious food from a local eatery and optional guided tours of the Rev1 Labs facility.